Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
58 /100
HIGH RISK
Score updated Aug 28, 2026

BCDA — BioCardia, Inc. Dilution Risk Tracker

Track BCDA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BCDA — Get alerts when the score changes →

As of August 28, 2026, BioCardia, Inc. (BCDA) has a DilutionWatch DilutionScore of 58/100, rated HIGH dilution risk. BioCardia, Inc. has a market capitalization of $10.58M, 15.14M shares outstanding, 18 institutional holders tracked. Stored dilution-related fields include 296.3K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
50
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 24%
🔄 Reverse Split model est. 40%
• 50-day avg $1.12 approaching $1 threshold
• 10 months cash with weak price
💰 Capital Raise model 15%
• Under 12 months cash (10mo)
🔔 Track BCDA — Get forecast alerts →

Market Data

Market Cap$10.58M
Shares Outstanding15.14M
Float8.76M
Cash$5.92M
Debt$412.0K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 25.7% shares (2026Q1 vs prior)
18 institutional holders · 817.4K shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 249.2K shares
#2 CM Management, LLC 130.0K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 94.3K shares
+ 15 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.11M
Days to Cover5.1
% of Float12.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30
xbrl XBRL CONVERTIBLE 2019-12-31
4 INSIDER TRANSACTION 2026-04-22
4 INSIDER TRANSACTION 2026-03-26
4 INSIDER TRANSACTION 2026-02-04
Full SEC filing analysis available with free account

Recent News

No recent news

Factual BCDA Dilution Snapshot

BioCardia, Inc. (BCDA) has a DilutionScore of 58/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track BCDA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BCDA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BCDA
BCDA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.